Bud Genius Inc. (OTC: RIGH), a leading cannabis laboratory and branding specialist, recently announced the addition of Dr. Peter Wilson, Ph.D., to its Executive Advisory Board. Dr. Wilson is a well-known and highly-respected expert in accounting, financial reporting, and business law with over 25 years of experience in corporate finance and 19 years at Duke University’s Fuqua School of Business.
“We are pleased to have Dr. Wilson join the company’s Executive Advisory Board and look forward to his contributions,” said Bud Genius Inc. CEO Angel Stanz in a press release announcing Dr. Wilson’s appointment. “As an expert in corporate finance, accounting, and financial reporting, Dr. Wilson will provide expertise in areas that can profoundly impact the future of our company.”
The move comes shortly after the company’s landmark agreement to acquire Evergreen Licensing. As the exclusive licensor of Tommy Chong marijuana, hemp, and cannabis-related products, the acquisition provides the company with a unique branding opportunity within the multi-billion dollar industry. Under the terms, the firm will manage licensing and distribution of branded products in California.
Moving forward, management plans to continue pursuing several business objectives throughout 2015, including the launch of its new mobile app and further celebrity licensing deals from media, sports, and entertainment genres. The company also plans to change its ticker symbol to better reflect its endeavors. Shareholders and investors interested in company’s current and future revenue drivers, including Marijuana Testing and Profiling, Licensing and Branding, Distribution and Supply Chain Optimization, and Healthcare Delivery Technology will find additional information at www.BGMedtech.com and www.BudGenius.com.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.